VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
MOS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
MOSThe Mosaic Company
$22.36$7.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMOSFinancials

The Mosaic Company (MOS) Income Statement

30Y historyFree accessUpdated daily

Revenue held near $2.6B to $3.5B across the period, yet gross margin fell from 18.6% in 2025Q1 to 2.7% in 2026Q3 and operating margin swung to -3.1%, indicating that cost inflation is absorbing top-line gains.

Income StatementBalance SheetCash FlowRatios

MOS Income Statement

Annual statement

MOS Income Statement

The Mosaic Company (MOS) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13May'13May'12May'11May'10May'09May'08May'07May'06May'05Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Jun'97
Sales/Revenue11.53B12.05B11.12B13.7B19.13B12.36B8.68B8.91B9.59B7.41B7.16B8.9B9.06B8.17B9.97B11.11B9.94B6.76B10.3B9.81B5.77B5.31B4.4B2.19B2.06B1.96B2.1B2.37B2.7B2.99B2.98B
Revenue Growth %-3.1%8.36%-18.79%-28.39%54.77%42.34%-2.52%-7.1%29.39%3.44%-19.48%-1.77%10.84%-18.09%-10.21%11.77%47.03%-34.36%4.95%69.95%8.82%20.68%100.71%6.47%5.04%-6.55%-11.54%-12.12%-9.78%0.22%0.03%
Cost of Goods Sold10.62B10.24B9.61B11.49B13.37B9.16B7.62B8.01B8.09B6.57B6.35B7.18B7.13B6.75B7.21B8.02B6.82B5.07B7.53B6.65B4.85B4.67B3.87B2.01B1.79B1.77B1.59B1.59B1.71B2.07B2.03B
COGS % of Revenue-84.92%86.41%83.86%69.9%74.1%87.73%89.93%84.37%88.63%88.69%80.69%78.73%82.62%72.33%72.23%68.59%74.95%73.13%67.79%83.96%87.99%88.05%91.73%87.22%90.36%75.97%67.28%63.28%69.16%67.99%
Gross Profit903.4M1.82B1.51B2.21B5.76B3.2B1.06B897.3M1.5B842.8M810M1.72B1.93B1.42B2.76B3.08B3.12B1.69B2.77B3.16B926.1M637.4M525.5M181.2M263M188.9M503.7M775.2M990.1M921.8M954.4M
Gross Margin %7.84%15.07%13.59%16.14%30.1%25.9%12.27%10.07%15.63%11.37%11.31%19.31%21.27%17.38%27.67%27.77%31.41%25.05%26.87%32.21%16.04%12.01%11.95%8.27%12.78%9.64%24.03%32.72%36.72%30.84%32.01%
Gross Profit Growth %-20.17%-31.61%-61.59%79.85%200.53%18.68%-40.12%77.79%4.05%-52.85%-10.83%35.68%-48.56%-10.53%-1.18%84.36%-38.8%-12.46%241.27%45.29%21.29%190.01%-31.1%39.23%-62.5%-35.02%-21.7%7.41%-3.42%3.8%
Operating Expenses1.17B767.2M890.4M872.5M970.5M731.8M652M1.99B570.1M377.1M491M439.1M614.8M548.4M550.6M473.9M457.6M422.5M365.8M353.8M309.8M531.6M207M54.8M80.7M92.8M101.5M360.3M374.7M315M431.6M
OpEx % of Revenue-6.37%8.01%6.37%5.07%5.92%7.51%22.37%5.95%5.09%6.85%4.94%6.79%6.71%5.52%4.27%4.6%6.25%3.55%3.61%5.37%10.02%4.71%2.5%3.92%4.74%4.84%15.21%13.9%10.54%14.47%
Selling, General & Admin497.5M520.9M496.9M500.5M498M430.5M371.5M354.1M341.1M301.3M304.2M361.2M382.4M363.09M427.3M410.1M372.5M360.3M321.4M335.5M309.8M241.3M207M79.6M80.7M81.8M102.7M164.5M190.4M435.6M247.2M
SG&A % of Revenue-4.32%4.47%3.65%2.6%3.48%4.28%3.98%3.56%4.07%4.25%4.06%4.22%4.44%4.28%3.69%3.75%5.33%3.12%3.42%5.37%4.55%4.71%3.63%3.92%4.18%4.9%6.94%7.06%14.58%8.29%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses4M249.1M393.5M372M472.5M301.3M280.5M1.64B229M75.8M186.8M77.9M232.4M0123.3M63.8M85.1M62.2M44.4M30M0290.3M0-24.8M011M-1.2M232.5M251.7M183.2M184.4M
Operating Income-269.4M1.05B621.5M1.34B4.79B2.47B412.9M-1.09B928.3M465.7M319M1.28B1.31B961.2M2.21B2.61B2.66B1.27B2.4B2.81B616.3M105.8M318.5M126.4M182.3M96.1M227.2M311.6M512M443.1M522.8M
Operating Margin %-2.34%8.71%5.59%9.77%25.02%19.98%4.76%-12.29%9.68%6.29%4.45%14.38%14.49%11.76%22.15%23.51%26.81%18.8%23.31%28.6%10.67%1.99%7.24%5.77%8.86%4.91%10.84%13.15%18.99%14.83%17.53%
Operating Income Growth %-68.9%-53.55%-72.04%93.85%497.84%137.71%-217.95%99.33%45.99%-75.05%-2.52%36.48%-56.5%-15.38%-1.99%109.65%-47.07%-14.46%355.41%482.51%-66.78%151.98%-30.66%89.7%-57.7%-27.09%-39.14%15.55%-15.24%-0.89%
EBITDA899.4M2.1B1.65B2.3B5.72B3.28B1.26B-149.8M1.81B1.13B1.03B2.02B2.06B1.66B2.81B3.12B3.11B1.72B2.76B3.16B929.6M376M499.2M298.3M347.6M253.3M398.8M544.1M763.7M626.3M707.2M
EBITDA Margin %7.8%17.42%14.81%16.78%29.9%26.55%14.52%-1.68%18.9%15.27%14.38%22.69%22.78%20.32%28.22%28.08%31.31%25.39%26.81%32.22%16.1%7.09%11.35%13.62%16.9%12.93%19.03%22.96%28.33%20.96%23.72%
EBITDA Growth %-57.55%27.48%-28.35%-59.81%74.29%160.33%941.46%-108.27%60.2%9.8%-48.96%-2.14%24.24%-41.01%-9.77%0.24%81.35%-37.86%-12.67%240.15%147.23%-24.68%67.35%-14.18%37.23%-36.48%-26.7%-28.75%21.94%-11.44%1.59%
D&A (Non-Cash Add-back)1.17B1.05B1.03B960.6M933.9M812.9M847.6M945.1M883.9M665.5M711.2M739.8M750.9M699.09M604.8M508.1M447.4M445M360.5M355.3M313.3M270.2M180.7M171.9M165.3M157.2M171.6M232.5M251.7M183.2M184.4M
EBIT166M1.43B545.4M1.51B4.81B2.42B395M-1.04B767.3M545.3M383M1.24B1.35B869.15M2.21B2.63B3.3B1.26B3B2.81B614.2M393.4M318.5M132.9M182.3M107.1M227.2M311.6M512M443.1M522.8M
Net Interest Income-217.7M-179.4M-182.8M-129.4M-137.8M-169.1M-180.6M-182.9M-166.1M-138.1M-112.4M-97.8M-107.6M018.8M18.7M-5.1M-49.6M-43.3M-90.5M00000000000
Interest Income10M38.3M47.2M59.6M31M25.2M33.5M33.1M49.7M33.2M28.2M35.8M21.3M22.8M18.8M20.1M22.5M16.1M46.9M33.5M00000000000
Interest Expense227.7M217.7M230M189M168.8M194.3M214.1M216M215.8M171.3M140.6M133.6M128.9M001.4M27.6M65.7M90.2M124M00000000000
Other Income/Expense-197.1M165.5M-232.8M48.1M53.2M-235.9M-325.8M-220.6M-381.3M-75M-92M-177.9M-96.7M-131.14M23.2M31.1M602.1M-92M604.9M-300K-73.2M-221.9M-52.6M-200.5M-166.3M-148.5M-96.1M-702.4M-282.3M-342.9M-200.8M
Pretax Income-466.9M1.22B388.7M1.39B4.84B2.23B87.1M-1.32B547M390.7M227M1.1B1.22B830.06M2.23B2.64B3.27B1.18B3.01B2.81B543.1M-116.1M265.9M-74.1M16M-52.4M131.1M-390.8M229.7M100.2M322M
Pretax Margin %-4.05%10.08%3.49%10.12%25.3%18.07%1%-14.77%5.71%5.27%3.17%12.38%13.42%10.16%22.39%23.79%32.87%17.44%29.19%28.6%9.41%-2.19%6.05%-3.38%0.78%-2.68%6.26%-16.49%8.52%3.35%10.8%
Income Tax-43.2M639.8M186.7M177M1.22B597.7M-578.5M-224.7M77.1M494.9M-74.2M99.1M184.7M261.6M341M711.4M752.8M347.3M649.3M714.9M123.4M5.3M98.3M-36.5M29.8M-10.4M46.8M141.3M99.9M30.4M117.5M
Effective Tax Rate %9.25%52.65%48.03%12.77%25.3%26.77%-664.18%17.08%14.1%126.67%-32.69%9%15.2%31.52%15.27%26.92%23.05%29.46%21.6%25.47%22.72%-4.57%36.97%49.26%186.25%19.85%35.7%-36.16%43.49%30.34%36.49%
Net Income-440.3M540.7M174.9M1.16B3.58B1.63B666.1M-1.07B470M-107.2M297.8M1B1.03B576M1.89B1.93B2.51B827.1M2.35B2.08B419.7M-121.4M165.6M-135.4M-110.8M-80.6M-345M-773.3M-9M62.9M193.1M
Net Margin %-3.82%4.49%1.57%8.51%18.73%13.2%7.67%-11.98%4.9%-1.45%4.16%11.25%11.36%7.05%18.94%17.38%25.3%12.24%22.82%21.23%7.27%-2.29%3.77%-6.18%-5.39%-4.12%-16.46%-32.64%-0.33%2.1%6.48%
Net Income Growth %-135.82%209.15%-84.99%-67.49%119.72%144.8%162.4%-327.11%538.43%-136%-70.23%-2.74%78.58%-69.5%-2.15%-23.24%204.03%-64.81%12.84%396.26%445.72%-173.31%222.3%-22.2%-37.47%76.64%55.39%-8492.22%-114.31%-67.43%33.82%
Net Income (Continuing)-423.7M575.4M202M1.21B3.61B1.63B665.6M-1.09B469.9M-104.2M301.2M1B1.03B568.46M1.89B1.93B2.51B831.5M2.36B2.09B419.7M-121.4M167.6M-37.6M-13.8M-42M84.3M-532.1M129.8M69.8M204.5M
Discontinued Operations00000000000006.86M000000000-92.9M-96.4M0-429.3M-234.2M-141.8M18M0
Minority Interest177.7M149.3M132.3M142.6M139.6M144.4M173.8M182.1M207.4M21.6M37.9M33.2M17.5M18.3M17.5M16.3M20.3M26.2M22.2M23.4M22.3M20.4M21.8M0000000437.3M
EPS (Diluted)-1.391.700.553.5010.064.271.75-2.691.22-0.310.852.782.681.364.424.425.621.855.274.670.95-0.320.46-1.18-0.96-0.58-3.01-6.75-0.080.672.03
EPS Growth %-134.46%209.09%-84.29%-65.21%135.6%144%165.06%-320.49%493.55%-136.47%-69.42%3.73%97.06%-69.23%0%-21.35%203.78%-64.9%12.85%391.58%396.88%-169.57%138.98%-22.92%-65.52%80.73%55.41%-8337.5%-111.94%-67%30.13%
EPS (Basic)-1.700.553.5210.174.311.76-2.691.22-0.310.852.792.691.374.444.545.641.865.294.700.97-0.320.51-1.18-0.96-0.58-3.02-6.75-0.080.672.03
Diluted Shares Outstanding317.9M318.9M320.7M333.2M356M381.6M381.3M383.8M386.4M350.9M351.7M360.3M375.6M422M426.9M436.5M447.5M446.6M446.2M445.7M440.3M382.2M360.4M114.8M114.6M114.5M114.8M114.56M112.5M93.88M95.12M
Basic Shares Outstanding317.9M317.3M319.8M331.3M352.4M378.1M379M383.8M384.8M345.81M350.4M358.5M374.1M420.8M425.82M425.47M446M445.1M444.2M442.7M434.3M382.2M327.8M114.8M114.6M114.5M114.4M114.56M112.5M93.88M95.12M
Dividend Payout Ratio-51.86%154.77%30.18%5.52%6.36%11.38%-8.19%-129.31%38.45%37.19%63.54%22.59%6.19%3.55%80.76%3.78%-0.62%-6.88%------47.22%15.59%

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Sulfur-driven phosphate margin compression

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Top-Line Growth Masks Deteriorating Volume Economics

Based on reported figures, Mosaic's revenue grew 8.4% year over year, yet this top-line expansion coincided with a swing to operating losses in the most recent quarters, suggesting price or volume gains are not reaching the bottom line.

The reported revenue growth rate of 8.4% against an operating margin near negative territory indicates that incremental sales are being generated at unprofitable unit economics. This pattern suggests the growth may be driven by lower-margin Fertilizantes distribution volume or by pricing that fails to offset input cost inflation. Investors should monitor whether the revenue trajectory can be sustained without further margin erosion, as growth that does not convert to operating profit warrants skepticism about its quality.

Gross Margin Compression Signals Cost Squeeze

As reported in the income statement, gross margin fell from roughly 18.6% in early 2025 to 2.7% in the latest quarter, a contraction of nearly 16 percentage points that points to a structural input cost problem rather than routine cyclicality.

The steep decline in gross margin across consecutive quarters is consistent with a squeeze between elevated sulfur and ammonia costs and softening DAP and MAP pricing. Management commentary attributing the drag to sulfur availability suggests the pressure is supply-side rather than purely demand-driven. The duration of sulfur market tightness will likely determine whether margins can recover toward historical levels, and the current trajectory does not yet suggest a durable reversal.

Negative Operating Leverage Amplifies Revenue Weakness

Based on the quarterly data, operating income swung from positive levels in 2025 to losses of roughly $96.6 million in the latest quarter, while SG&A remained near $124 to $136 million, showing fixed overhead absorbing a shrinking gross profit base.

Because SG&A has remained relatively stable while gross profit has collapsed, the operating cost base is not scaling down with the business, producing negative operating leverage in both directions. This means that the same fixed-cost structure that amplified earnings during the 2025 price recovery is now magnifying losses. Investors should recognize that restoring profitability depends heavily on gross margin recovery rather than overhead reduction.

Net Losses Diverge From Revenue Stability

Reported net income turned negative at -$272.8 million in the second quarter of 2026 despite revenue of roughly $2.8 billion, and EPS of -0.86 contrasted sharply with the prior-year positive results, which appears to reflect operating cost pressure rather than one-time items.

The gap between stable revenue and deeply negative net income suggests the loss is driven by operating deterioration instead of large non-operating charges, though the data alone cannot confirm the composition of below-the-line items. Stock-based compensation remains small relative to the magnitude of losses, so it does not appear to distort the earnings picture materially. Investors should examine the reconciliation of operating to net income to confirm whether impairments or tax effects are contributing further downside.

Raw Material Inputs Dominate the Cost Base

Cost of goods sold absorbed roughly 97% of revenue in the latest quarter, with COGS near $3.0 billion against $3.1 billion of sales, indicating that input costs such as sulfur and ammonia are the dominant driver of the current earnings problem.

The near-total absorption of revenue by COGS implies that the variable cost of raw materials is overwhelming realized selling prices in the Phosphates segment. This suggests management has limited near-term ability to offset input inflation through cost discipline alone, as the cost lines themselves are commodity-linked. Monitoring the sulfur and ammonia spread against DAP pricing will be more informative than tracking SG&A, which has remained comparatively contained.

Recovery Thesis Faces Credible Downside Risks

The bullish case for recovery rests on the K3 potash mine lowering costs, yet the reported Q2 2026 EPS miss of -0.86 against a $0.22 estimate suggests the offsetting benefit is currently insufficient against phosphate cost inflation.

The strongest counter-argument is that the K3 potash cost advantage has not yet been large enough to offset phosphate-side deterioration, and that lowered guidance implies management itself does not expect near-term relief. If sulfur tightness persists or the phosphate crack spread stays compressed, the market may continue to reprice the stock lower. Investors should treat the structural depletion thesis as a long-dated argument that does not currently support near-term earnings.

MOS — Frequently Asked Questions

Quick answers to the most common questions about buying MOS stock.

What was The Mosaic Company's (MOS) revenue in 2025?

For fiscal year 2025, The Mosaic Company (MOS) reported total revenue of $12.05B. This represents a 304.2% increase compared to $2.98B in 1996.

Is The Mosaic Company (MOS) profitable?

The Mosaic Company (MOS) is profitable, generating $540.7M in net income for the fiscal year ending 2025 with a net profit margin of 4.5%.

What is The Mosaic Company's operating profit margin?

The Mosaic Company (MOS) reported an operating income of $1.05B, resulting in an operating profit margin of 8.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is The Mosaic Company's gross profit and gross margin?

The Mosaic Company (MOS) generated $1.82B in gross profit for the year, representing a gross profit margin of 15.1%. This demonstrates the company's core pricing power and production efficiency.